Agenda
9:40 AM — 9:50 AM
WELCOME AND OPENING REMARKS9:50 AM — 10:20 AM
What is Biosimilar? Development Overview10:20 AM — 10:50 AM
Expectations for Biosimilars10:50 AM — 11:20 AM
The Challenges of Proof of Similarity for Biosimilar Development11:20 AM — 11:50 AM
Application of QbD Tools for Biosimilar Products1:00 PM — 1:30 PM
Experience of Biosimilar Development 1 - CMC Perspective2:00 PM — 2:30 PM
Review of Biosimilars in Japan2:30 PM — 3:00 PM
The Current Situation of Biosimilars Worldwide3:30 PM — 4:30 PM
The Evolution of EU Guidelines and the Current Situation for Biosimilars4:30 PM — 5:30 PM
Panel DiscussionHave an account?